Stay updated on Clinical Trial: Reboxetine in Narcolepsy & Cataplexy

Sign up to get notified when there's something new on the Clinical Trial: Reboxetine in Narcolepsy & Cataplexy page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: Reboxetine in Narcolepsy & Cataplexy page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Narcolepsy is now listed as a topic and a Genetic and Rare Diseases Information Center resource was added under resources, with the page updated to v3.4.2. The funding-status notice and the previous v3.4.1 revision note were removed.
    Difference
    0.6%
    Check dated 2026-02-11T02:46:22.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a government funding lapse notice informing users that information may not be up to date and transactions may not be processed. Updated the site revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T00:22:08.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a glossary display, updated QC metadata labels (Last Update Submitted that Met QC Criteria), added No FEAR Act Data, and introduced Revision: v3.4.0. Removed the older QC wording (Last Update Submitted that met QC Criteria), removed No FEAR Act data, and removed the v3.3.4 revision label.
    Difference
    0.2%
    Check dated 2026-01-27T23:21:07.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page shows a minor version update from v3.3.3 to v3.3.4 with no visible changes to study details, eligibility criteria, or locations. No impact on trial information or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:06:28.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page now includes an expanded Locations section listing study sites by state (Alabama, California, Colorado, Florida, Georgia, Indiana, Maryland, New York, Ohio, South Carolina, Texas) and a revision tag v3.3.3. Per-state location headers were consolidated under a single Locations section.
    Difference
    1%
    Check dated 2025-12-23T10:21:55.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision tag updated from v3.2.0 to v3.3.2. No changes to the study details or page functionality were observed.
    Difference
    0.1%
    Check dated 2025-11-24T19:03:25.000Z thumbnail image

Stay in the know with updates to Clinical Trial: Reboxetine in Narcolepsy & Cataplexy

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Reboxetine in Narcolepsy & Cataplexy page.